WASHINGTON - President Donald Trump said Monday that the administration's TrumpRx prescription drug platform would add more ...

Milestone Pharmaceuticals Inc (MIST) reports a successful product launch and strategic trials, despite facing early-stage revenue hurdles and increased expenses.

The company initiated its next development program for etripamil, starting a Phase III AFib-RVR trial. “We have initiated our Phase III trial for atrial fibrillation with rapid ventricular rate or ...

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress ...

If you've been relying on Express Scripts for your 90-day refills and home delivery, 2026 brings a critical shift: a new 'Copay Assurance' program that caps out-of-pocket costs, paired with stricter ...

Running two drugstores is a break-even endeavor for Primary Care Pharmacy Services owner Anthony Bertola, as long as he ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, ...

The Medicare agency will extend a short-term program that will pay for weight-loss drugs such as Eli Lilly’s Zepbound and Novo Nordisk’s NOVO.B-1.76%decrease; red down pointing triangle Wegovy, ...